SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001390777-11-000117
Filing Date
2011-04-08
Accepted
2011-04-08 13:59:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 amylin.txt SC 13G/A 42971
  Complete submission text file 0001390777-11-000117.txt   44513
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42168 | Film No.: 11748918
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE WALL STREET NEW YORK NY 10286
Business Address ONE WALL STREET NEW YORK NY 10286 212-495-1784
Bank of New York Mellon CORP (Filed by) CIK: 0001390777 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6022 State Commercial Banks